Optimized cross-shaped PMMA fibers enable efficient, selective β2-MG removal and favorable flow dynamics for hemoperfusion therapies targeting mid-weight uremic toxins.
Share your take
Add a clinician perspective alongside expert commentary.
Fujieda et al. (2026) studied this question.